InMed Pharmaceuticals Inc

InMed Pharmaceuticals Inc(INM)价格预测

$14.425

+1.327 (+9.20%)收盘时

价格预测

1-Day Price Prediction
+7.73%
1-Week Prediction
+13.72%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

在 App 中打开以解锁更长周期的预测。

Loading chart…

INM 相似图表分析预测

Alphio's INM stock price prediction model matches the current InMed Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $15.54 (+7.73%). The 1-week path is $16.40 (+13.72%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

该买入 InMed Pharmaceuticals Inc 股票吗?

InMed Pharmaceuticals, now Mentari Therapeutics, is a good buy right now due to its recent merger which is expected to enhance market competitiveness. The stock has shown a 9.20% increase yesterday, indicating positive momentum, and the forward P/E is currently at 0, suggesting potential for future earnings growth. However, the company reported a net income loss of -5,839,392 USD in Q4 2026, which remains a risk factor.

INM 股价于 Friday 收于 $14.43,此前上涨 +9.20%

InMed Pharmaceuticals Inc (INM) last closed at $14.4250002, gaining +9.20%. These facts feed the 1-day and 1-week INM price prediction above.

预测驱动因素

InMed Pharmaceuticals Inc(INM)的预测驱动因素综合了相似的图表形态、季节性与移动平均线。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Positive

Bullish

相似图表形态

近期走势与 INM 最接近的股票,按相似度排序。

INM 季节性分析

Historically the probability of a positive November return for INM is 11.36%. August offers the highest probability of a positive month at 40.62%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易